Literature DB >> 33176942

Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.

Nicholas I Goldenson1, August R Buchhalter2, Erik M Augustson3, Mark L Rubinstein3, Jack E Henningfield2.   

Abstract

BACKGROUND: The abuse liability of the JUUL System (JS) in four flavors were evaluated compared to combustible cigarettes, nicotine gum, and a comparator electronic nicotine delivery system (ENDS) with pharmacokinetics (PK) and subjective effects.
METHODS: Adult smokers (N = 66; 50.0 % female; mean age = 41.1; 63.6 % white) completed a 7-arm within-subjects cross-over product-use study while confined to a clinical laboratory. Participants used JS in four flavors (Virginia Tobacco, Mango, Mint, Creme, [5.0 % nicotine; 59 mg/mL]), their usual brand (UB) cigarette, a comparator ENDS (VUSE Solo; 4.8 % nicotine, tobacco-flavor), and mint nicotine gum (4 mg) under controlled use conditions. After each product use, nicotine PK and subjective effects were assessed.
RESULTS: Maximum plasma nicotine levels (Cmax-BL), rate of plasma nicotine rise, overall nicotine exposure (AUC0-60-BL), and subjective liking and satisfaction of JS were significantly lower than UB cigarettes. These parameters were generally greater for JS than nicotine gum; the comparator ENDS was somewhat lower but within the range of JS. Nicotine PK did not differ among the Mint, Mango, and Virginia Tobacco JS flavors. Mint and Mango were rated as more satisfying than Virginia Tobacco and Creme.
CONCLUSIONS: Controlled use of JS among adult smokers resulted in nicotine delivery, product liking, and satisfaction that were less than that of combustible cigarettes but generally greater than nicotine gum. These results support the conclusion that JS has lower abuse liability than combustible cigarettes, higher abuse liability than nicotine gum, and may provide sufficient nicotine delivery and satisfying effects to support substitution for combustible cigarettes among adult smokers.
Copyright © 2020 Juul Labs, Inc. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abuse liability; Cigarette; Electronic nicotine delivery system; Flavor; JUUL; Pharmacokinetics

Mesh:

Substances:

Year:  2020        PMID: 33176942     DOI: 10.1016/j.drugalcdep.2020.108395

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  8 in total

1.  Comparison of brain nicotine uptake from electronic cigarettes and combustible cigarettes.

Authors:  Yantao Zuo; Kiran Kumar Solingapuram Sai; Alexey G Mukhin; Hannah Berg; Janiece D Morgan; Akiva Mintz; Jed E Rose
Journal:  Neuropsychopharmacology       Date:  2022-08-12       Impact factor: 8.294

2.  A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers.

Authors:  Ian M Fearon; Karin Gilligan; Ryan G N Seltzer; Willie McKinney
Journal:  Harm Reduct J       Date:  2022-06-02

3.  Nicotine delivery and relief of craving after consumption of European JUUL e-cigarettes prior and after pod modification.

Authors:  Nadja Mallock; Andrea Rabenstein; Solveig Gernun; Peter Laux; Christoph Hutzler; Susanne Karch; Gabriele Koller; Frank Henkler-Stephani; Maria Kristina Parr; Oliver Pogarell; Andreas Luch; Tobias Rüther
Journal:  Sci Rep       Date:  2021-06-08       Impact factor: 4.379

4.  Drug and alcohol dependence acute effects of pod-style e-cigarettes in vaping-naïve smokers.

Authors:  Natalia Peraza; Mariel S Bello; Sara J Schiff; Junhan Cho; Yi Zhang; Carly Callahan; Alayna Tackett; Adam M Leventhal
Journal:  Drug Alcohol Depend       Date:  2021-09-21       Impact factor: 4.492

Review 5.  Nicotine delivery and cigarette equivalents from vaping a JUULpod.

Authors:  Judith J Prochaska; Erin A Vogel; Neal Benowitz
Journal:  Tob Control       Date:  2021-03-24       Impact factor: 6.953

6.  A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products.

Authors:  David Azzopardi; James Ebajemito; Michael McEwan; Oscar M Camacho; Jesse Thissen; George Hardie; Richard Voisine; Gavin Mullard; Zvi Cohen; James Murphy
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

7.  Nicotine pharmacokinetics and subjective responses after using nicotine pouches with different nicotine levels compared to combustible cigarettes and moist smokeless tobacco in adult tobacco users.

Authors:  Jianmin Liu; Jesse Rensch; Jingzhu Wang; Xiaohong Jin; Andrea Vansickel; Jeffery Edmiston; Mohamadi Sarkar
Journal:  Psychopharmacology (Berl)       Date:  2022-07-23       Impact factor: 4.415

8.  An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy.

Authors:  George Hardie; Nathan Gale; Michael McEwan; Stefano Milleri Oscar; Luigi Ziviani; Christopher J Proctor; James Murphy
Journal:  Sci Rep       Date:  2022-08-29       Impact factor: 4.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.